Medication Guide App

Epanova Approval Status beta

  • FDA approved: No
  • Brand name: Epanova
  • Company: Omthera Pharmaceuticals, Inc.
  • Treatment for: Hypertriglyceridemia

Epanova is a complex mixture of concentrated omega-3 free fatty acids in development for the treatment of patients with severe hypertriglyceridemia.

FDA Approval Status for Epanova

DateArticle
Sep 18, 2013FDA Accepts New Drug Application for Investigational Compound Epanova for the Treatment of Severe Hypertriglyceridemia
Jul  9, 2013Omthera Pharmaceuticals Announces NDA Submission for Epanova for the Treatment of Patients with Very High Triglycerides

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web1)